Sun Pharmaceutical Inds. Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1993

Chairman: Israel Makov

Managing Director: Dilip S Shanghvi

Group: Sun Pharma

Listing: NSE: SUNPHARMA, BSE: 524715

Headquarters: Vadodara, Gujarat

Website: www.sunpharma.com

Key Facts

Market cap: R 1,09,217.73 Cr

Revenue (TTM): R 31,816.48 Cr

Earnings (TTM): R 4,415.49 Cr

Cash: R 11,226.32 Cr

Total Debt: R 10,514.36 Cr

Promoters' ownership: 54.56%

Liquidity: High

52 Week range: R 312.00 - 479.90

Face value: R1.00

Shares outstanding: 2,39,93,34,970

Stock Performance

Trailing
Annual

Time Period	Sun Pharmaceutical Inds.	S&P BSE Sensex	S&P BSE Healthcare
YTD	5.06	-24.47	8.37
1 month	15.53	-12.56	7.76
3 months	3.32	-24.83	7.54
1 Year	-3.50	-19.98	1.26
3 Years	-11.93	1.60	-1.47
5 Years	-16.39	1.53	-4.36
10 Years	9.88	5.68	10.52

As on 09-Apr-2020

Year	Sun Pharmaceutical Inds.	S&P BSE Sensex	S&P BSE Healthcare
2019	-0.23	14.38	-3.55
2018	-24.51	5.87	-5.89
2017	-9.34	27.91	0.49
2016	-22.75	1.95	-12.88
2015	-0.25	-5.03	15.06
2014	44.41	29.89	47.43
2013	53.47	8.98	22.55

Annual Report (FY18)

Review & Analysis

A hunt for quality large caps available cheap
Jugal Harpalani . 09-Oct-2019
Steely discipline
17-May-2018
Value your funds
Kumar Shankar Roy . 29-Jan-2018
More than meets the eye
Yash Rohra . 17-Oct-2017
The unusual five
Mohammed Ekramul Haque . 06-Feb-2017

News & Announcements

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
03-Apr-2020
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
01-Apr-2020
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
01-Apr-2020
Update On Halol Facility
29-Mar-2020
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
26-Mar-2020